{"url":"https://lda.gov/api/v1/filings/30d0d469-13d7-4a24-b611-12466bf7afe5/","filing_uuid":"30d0d469-13d7-4a24-b611-12466bf7afe5","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2025,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/30d0d469-13d7-4a24-b611-12466bf7afe5/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Brian Pomper","dt_posted":"2025-04-21T11:25:45-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2001 K Street NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":682,"url":"https://lda.gov/api/v1/registrants/682/","house_registrant_id":31784,"name":"AKIN GUMP STRAUSS HAUER & FELD","description":"Law firm","address_1":"2001 K St NW","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRIAN POMPER","contact_telephone":"+1 202-887-4000","dt_updated":"2026-01-30T20:42:28.553875-05:00"},"client":{"id":101173,"url":"https://lda.gov/api/v1/clients/101173/","client_id":1007538,"name":"UNITED STATES PHARMACOPEIAL CONVENTION","general_description":"Organization that sets standards for medicines, food ingredients, and dietary supplements.","client_government_entity":false,"client_self_select":null,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-04-13"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to the Pandemic and All-Hazards Preparedness Act (P.L. 109-417)(PAHPA) reauthorization; Issues related to the pharmaceutical supply chain, drug shortages, advanced manufacturing, and pharmaceutical standards.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68831,"prefix":null,"prefix_display":null,"first_name":"SEAN","nickname":null,"middle_name":null,"last_name":"FEELY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":104715,"prefix":null,"prefix_display":null,"first_name":"ANNA","nickname":null,"middle_name":null,"last_name":"ABRAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147654,"prefix":null,"prefix_display":null,"first_name":"KANDIS","nickname":null,"middle_name":null,"last_name":"MCCLURE","suffix":null,"suffix_display":null},"covered_position":"Intern for Sen. Harry Reid, Jan. - Apr. 2013","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to pharmaceutical supply chains, drug quality, and drug testing.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68831,"prefix":null,"prefix_display":null,"first_name":"SEAN","nickname":null,"middle_name":null,"last_name":"FEELY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}